The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Generic Oncology Drugs Market Research Report 2024

Global Generic Oncology Drugs Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1804976

No of Pages : 87

global Generic Oncology Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Generic Oncology Drugs market research.

Key companies engaged in the Generic Oncology Drugs industry include Pfizer, GlaxoSmithKline, Novartis, Merck, Celgene, Teva Pharmaceutical, Mylan, Aurobindo Pharma and Hikma Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Generic Oncology Drugs were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Generic Oncology Drugs market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Generic Oncology Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Pfizer
  •     GlaxoSmithKline
  •     Novartis
  •     Merck
  •     Celgene
  •     Teva Pharmaceutical
  •     Mylan
  •     Aurobindo Pharma
  •     Hikma Pharmaceuticals
  •     Natco Pharma

Segment by Type

  •     Large Molecule Drugs
  •     Small Molecule Drugs

Segment by Application

  •     Hospital Pharmacies
  •     Retail Pharmacies
  •     Online Pharmacies

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil,Turkey, GCC Countries)

The Generic Oncology Drugs report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Generic Oncology Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Large Molecule Drugs
        1.2.3 Small Molecule Drugs
    1.3 Market by Application
        1.3.1 Global Generic Oncology Drugs Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Generic Oncology Drugs Market Perspective (2018-2029)
    2.2 Generic Oncology Drugs Growth Trends by Region
        2.2.1 Global Generic Oncology Drugs Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Generic Oncology Drugs Historic Market Size by Region (2018-2023)
        2.2.3 Generic Oncology Drugs Forecasted Market Size by Region (2024-2029)
    2.3 Generic Oncology Drugs Market Dynamics
        2.3.1 Generic Oncology Drugs Industry Trends
        2.3.2 Generic Oncology Drugs Market Drivers
        2.3.3 Generic Oncology Drugs Market Challenges
        2.3.4 Generic Oncology Drugs Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Generic Oncology Drugs Players by Revenue
        3.1.1 Global Top Generic Oncology Drugs Players by Revenue (2018-2023)
        3.1.2 Global Generic Oncology Drugs Revenue Market Share by Players (2018-2023)
    3.2 Global Generic Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Generic Oncology Drugs Revenue
    3.4 Global Generic Oncology Drugs Market Concentration Ratio
        3.4.1 Global Generic Oncology Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Generic Oncology Drugs Revenue in 2022
    3.5 Generic Oncology Drugs Key Players Head office and Area Served
    3.6 Key Players Generic Oncology Drugs Product Solution and Service
    3.7 Date of Enter into Generic Oncology Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Generic Oncology Drugs Breakdown Data by Type
    4.1 Global Generic Oncology Drugs Historic Market Size by Type (2018-2023)
    4.2 Global Generic Oncology Drugs Forecasted Market Size by Type (2024-2029)

 5 Generic Oncology Drugs Breakdown Data by Application
    5.1 Global Generic Oncology Drugs Historic Market Size by Application (2018-2023)
    5.2 Global Generic Oncology Drugs Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Generic Oncology Drugs Market Size (2018-2029)
    6.2 North America Generic Oncology Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Generic Oncology Drugs Market Size by Country (2018-2023)
    6.4 North America Generic Oncology Drugs Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Generic Oncology Drugs Market Size (2018-2029)
    7.2 Europe Generic Oncology Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Generic Oncology Drugs Market Size by Country (2018-2023)
    7.4 Europe Generic Oncology Drugs Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Generic Oncology Drugs Market Size (2018-2029)
    8.2 Asia-Pacific Generic Oncology Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Generic Oncology Drugs Market Size by Region (2018-2023)
    8.4 Asia-Pacific Generic Oncology Drugs Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Generic Oncology Drugs Market Size (2018-2029)
    9.2 Latin America Generic Oncology Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Generic Oncology Drugs Market Size by Country (2018-2023)
    9.4 Latin America Generic Oncology Drugs Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Generic Oncology Drugs Market Size (2018-2029)
    10.2 Middle East & Africa Generic Oncology Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Generic Oncology Drugs Market Size by Country (2018-2023)
    10.4 Middle East & Africa Generic Oncology Drugs Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Generic Oncology Drugs Introduction
        11.1.4 Pfizer Revenue in Generic Oncology Drugs Business (2018-2023)
        11.1.5 Pfizer Recent Development
    11.2 GlaxoSmithKline
        11.2.1 GlaxoSmithKline Company Detail
        11.2.2 GlaxoSmithKline Business Overview
        11.2.3 GlaxoSmithKline Generic Oncology Drugs Introduction
        11.2.4 GlaxoSmithKline Revenue in Generic Oncology Drugs Business (2018-2023)
        11.2.5 GlaxoSmithKline Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Generic Oncology Drugs Introduction
        11.3.4 Novartis Revenue in Generic Oncology Drugs Business (2018-2023)
        11.3.5 Novartis Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Generic Oncology Drugs Introduction
        11.4.4 Merck Revenue in Generic Oncology Drugs Business (2018-2023)
        11.4.5 Merck Recent Development
    11.5 Celgene
        11.5.1 Celgene Company Detail
        11.5.2 Celgene Business Overview
        11.5.3 Celgene Generic Oncology Drugs Introduction
        11.5.4 Celgene Revenue in Generic Oncology Drugs Business (2018-2023)
        11.5.5 Celgene Recent Development
    11.6 Teva Pharmaceutical
        11.6.1 Teva Pharmaceutical Company Detail
        11.6.2 Teva Pharmaceutical Business Overview
        11.6.3 Teva Pharmaceutical Generic Oncology Drugs Introduction
        11.6.4 Teva Pharmaceutical Revenue in Generic Oncology Drugs Business (2018-2023)
        11.6.5 Teva Pharmaceutical Recent Development
    11.7 Mylan
        11.7.1 Mylan Company Detail
        11.7.2 Mylan Business Overview
        11.7.3 Mylan Generic Oncology Drugs Introduction
        11.7.4 Mylan Revenue in Generic Oncology Drugs Business (2018-2023)
        11.7.5 Mylan Recent Development
    11.8 Aurobindo Pharma
        11.8.1 Aurobindo Pharma Company Detail
        11.8.2 Aurobindo Pharma Business Overview
        11.8.3 Aurobindo Pharma Generic Oncology Drugs Introduction
        11.8.4 Aurobindo Pharma Revenue in Generic Oncology Drugs Business (2018-2023)
        11.8.5 Aurobindo Pharma Recent Development
    11.9 Hikma Pharmaceuticals
        11.9.1 Hikma Pharmaceuticals Company Detail
        11.9.2 Hikma Pharmaceuticals Business Overview
        11.9.3 Hikma Pharmaceuticals Generic Oncology Drugs Introduction
        11.9.4 Hikma Pharmaceuticals Revenue in Generic Oncology Drugs Business (2018-2023)
        11.9.5 Hikma Pharmaceuticals Recent Development
    11.10 Natco Pharma
        11.10.1 Natco Pharma Company Detail
        11.10.2 Natco Pharma Business Overview
        11.10.3 Natco Pharma Generic Oncology Drugs Introduction
        11.10.4 Natco Pharma Revenue in Generic Oncology Drugs Business (2018-2023)
        11.10.5 Natco Pharma Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
Global Generic Oncology Drugs Market Research Report 2023
Industry: Medical Care

Published: 2023-06-11

Pages: 87 Pages

Report ld: 498239

申请样本
Request Sample

定制报告
Pre-Order Enquiry

CHOOSE LICENSE TYPE
 提示
USD 2900.00

 提示
USD 4350.00

 提示
USD 5800.00

/uploads/payment/payIcon/masterCard-01.svg/uploads/payment/payIcon/american-express-01.svg/uploads/payment/payIcon/visa-01.svg/uploads/payment/payIcon/diners-club-01.svg/uploads/payment/payIcon/discover-4-01.svg/uploads/payment/payIcon/jcb-01.svg
加入购物车
Add to Cart

立即购买
Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

Speak To Our Analyst >>
WHAT QYRESEARCH OFFER?
Competition
Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis
Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size
Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information
Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?
Global Generic Oncology Drugs Market Research Report 2023

Get A Free Sample >>
WHY QYR?
Fastest report delivery service
Fastest report delivery service

More than 16 years of vast experience
More than 16 years of vast experience

Operation for 24 * 7 & 365 days
Operation for 24 * 7 & 365 days

In-depth and comprehensive analysis
In-depth and comprehensive analysis

Professional and timely after-sales service
Professional and timely after-sales service

Owns large database
Owns large database

 

Published By : 9Dimen Research

Why ‘The Market Reports’